Concentrated Growth Factor from Autologous Platelet Promotes Hair Growth in Androgenetic Alopecia

Studies have shown that platelet concentrates can induce the proliferation of the dermal papilla and the vascularization of the perifollicular tissue, as well as accelerate the telogen-to-anagen transition, thereby promoting the regrowth of hair improving the appearance of hair loss. Herein, we report on the application of a new, modified form of platelet concentrates, namely, concentrated growth factors (CGFs), in 15 cases of androgenetic alopecia (AGA). 15 cases of androgenetic alopecia were treated with the use of monthly, subcutaneous injections of autologous CGF in the scalp. A total of 3 injections were administered 4 weeks apart, and the patients were followed up for 6 months. Assessments were performed before the treatments and at 4, 8, 12 and 24 weeks after the first treatment. The treatment outcomes were assessed by taking macroscopic photographs and trichoscopic photomicrographs, as well as by using the Global Aesthetic Improvement Scale (GAIS) and the patient satisfaction survey. In order to determine the safety of the treatment, the injection area was observed for signs of infection or mass evaluation. The photographs showed significant improvement in hair appearance after injections of CGF. The hair photomicrographs showed that CGF promoted the regrowth of hair in balding areas, with an increased hair density and an increased ratio of terminal to vellus hair. The GAIS suggested that CGF treatments were effective in treating AGA, and the majority of patients were satisfied with their improvement. In addition, treatments resulted in a faster rate of hair growth and a decrease in the greasy and unpleasant sensation of the hair of the patients. At the last visit, none of the 15 patients reported experiencing side-effects during the follow-up period. To conclude, the application of CGF can be an effective method in the treatment of androgenetic alopecia.

[1]  C. Kara,et al.  Effect of concentrated growth factor on osteoblast cell response. , 2018, Journal of stomatology, oral and maxillofacial surgery.

[2]  Kanyawat Rattanasuwan,et al.  Platelet-rich plasma stimulated proliferation, migration, and attachment of cultured periodontal ligament cells , 2018, European Journal of Dentistry.

[3]  W. Tian,et al.  Concentrated Growth Factor Enhanced Fat Graft Survival: A Comparative Study , 2018, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[4]  L. Rodella,et al.  In vitro treatment with concentrated growth factors (CGF) and sodium orthosilicate positively affects cell renewal in three different human cell lines , 2018, Cell biology international.

[5]  B. Piraccini,et al.  Evidence‐based (S3) guideline for the treatment of androgenetic alopecia in women and in men – short version , 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

[6]  C. Fuentes-Orozco,et al.  Platelet-rich plasma and its effect in bone regeneration in mandibular fractures. Controlled clinical trial , 2017, Gaceta medica de Mexico.

[7]  S. Giordano,et al.  Platelet‐rich plasma for androgenetic alopecia: Does it work? Evidence from meta analysis , 2017, Journal of cosmetic dermatology.

[8]  Kohya Uematsu,et al.  Mechanical and degradation properties of advanced platelet-rich fibrin (A-PRF), concentrated growth factors (CGF), and platelet-poor plasma-derived fibrin (PPTF) , 2017, International journal of implant dentistry.

[9]  Venkatesh Ponemone,et al.  Treatment of chronic non-healing ulcers using autologous platelet rich plasma: a case series , 2017, Journal of Biomedical Science.

[10]  J. Qiao,et al.  Quantification of growth factors in different platelet concentrates , 2017, Platelets.

[11]  A. Gupta,et al.  Meta-analysis of efficacy of platelet-rich plasma therapy for androgenetic alopecia , 2017, The Journal of dermatological treatment.

[12]  Jufang Zhang,et al.  Identification of key genes induced by platelet-rich plasma in human dermal papilla cells using bioinformatics methods , 2016, Molecular medicine reports.

[13]  K. Markou,et al.  Platelet-rich plasma in otolaryngology. , 2016, The Journal of laryngology and otology.

[14]  Aditya K. Gupta,et al.  A Mechanistic Model of Platelet-Rich Plasma Treatment for Androgenetic Alopecia , 2016, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[15]  V. Garelli,et al.  Multi‐therapies in androgenetic alopecia: review and clinical experiences , 2016, Dermatologic therapy.

[16]  Kohya Uematsu,et al.  Growth factor and pro-inflammatory cytokine contents in platelet-rich plasma (PRP), plasma rich in growth factors (PRGF), advanced platelet-rich fibrin (A-PRF), and concentrated growth factors (CGF) , 2016, International journal of implant dentistry.

[17]  S. Singla,et al.  Chronic Plantar Fasciitis: Effect of Platelet-Rich Plasma, Corticosteroid, and Placebo. , 2016, Orthopedics.

[18]  W. De-Eknamkul,et al.  Potential targets in the discovery of new hair growth promoters for androgenic alopecia , 2014, Expert opinion on therapeutic targets.

[19]  W. Bergfeld,et al.  Androgenetic Alopecia: An Evidence-Based Treatment Update , 2014, American Journal of Clinical Dermatology.

[20]  C. Sung,et al.  Exogenous IGF-1 promotes hair growth by stimulating cell proliferation and down regulating TGF-β1 in C57BL/6 mice in vivo. , 2014, Growth Hormone & IGF Research.

[21]  S. Inui,et al.  Androgen actions on the human hair follicle: perspectives , 2013, Experimental dermatology.

[22]  Jeung-Hoon Lee,et al.  Autologous Platelet‐Rich Plasma: A Potential Therapeutic Tool for Promoting Hair Growth , 2012, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[23]  A. Tosti,et al.  Evidence‐based (S3) guideline for the treatment of androgenetic alopecia in women and in men , 2011, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[24]  N. Harada,et al.  Dihydrotestosterone inhibits hair growth in mice by inhibiting insulin-like growth factor-I production in dermal papillae. , 2011, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[25]  L. Rodella,et al.  Growth factors, CD34 positive cells, and fibrin network analysis in concentrated growth factors fraction , 2011, Microscopy research and technique.

[26]  Gordon Guyatt,et al.  Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review. , 2010, Archives of dermatology.

[27]  Y. Liu,et al.  Prevalence of androgenetic alopecia in China: a community‐based study in six cities , 2009, The British journal of dermatology.

[28]  B. Eppley,et al.  Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. , 2004, Plastic and reconstructive surgery.

[29]  Y. Tabata,et al.  Promoted growth of murine hair follicles through controlled release of basic fibroblast growth factor. , 2002, Tissue engineering.

[30]  M. Detmar,et al.  Control of hair growth and follicle size by VEGF-mediated angiogenesis. , 2001, The Journal of clinical investigation.

[31]  D. Tobin,et al.  Active hair growth (anagen) is associated with angiogenesis. , 2000, The Journal of investigative dermatology.

[32]  M. Akiyama,et al.  Growth factor and growth factor receptor localization in the hair follicle bulge and associated tissue in human fetus. , 1996, The Journal of investigative dermatology.

[33]  L. Soroceanu,et al.  Loss of vascular endothelial growth factor in human alopecia hair follicles. , 1995, The Journal of investigative dermatology.